PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS
| الحاوية / القاعدة: | HemaSphere |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wiley
2022-06-01
|
| الوصول للمادة أونلاين: | http://journals.lww.com/10.1097/01.HS9.0000850168.39267.76 |
| _version_ | 1850273005630914560 |
|---|---|
| author | A. Navickas J. González M. M. Rivas M. Clavijo N. Carnelutto M. E. Funes M. J. Mela Osorio R. Mariano M. L. Rapan M. Moirano I. Rey S. Cranco J. E. Giunta R. Ramirez M. B. Castro A. Enrico A. Gimenez Conca C. Belli |
| author_facet | A. Navickas J. González M. M. Rivas M. Clavijo N. Carnelutto M. E. Funes M. J. Mela Osorio R. Mariano M. L. Rapan M. Moirano I. Rey S. Cranco J. E. Giunta R. Ramirez M. B. Castro A. Enrico A. Gimenez Conca C. Belli |
| author_sort | A. Navickas |
| collection | DOAJ |
| container_title | HemaSphere |
| format | Article |
| id | doaj-art-668dff43e9354cfca4b2ea6b0443dbfc |
| institution | Directory of Open Access Journals |
| issn | 2572-9241 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| spelling | doaj-art-668dff43e9354cfca4b2ea6b0443dbfc2025-08-19T23:42:04ZengWileyHemaSphere2572-92412022-06-0161709171010.1097/01.HS9.0000850168.39267.76202206003-01709PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTSA. Navickas0J. González1M. M. Rivas2M. Clavijo3N. Carnelutto4M. E. Funes5M. J. Mela Osorio6R. Mariano7M. L. Rapan8M. Moirano9I. Rey10S. Cranco11J. E. Giunta12R. Ramirez13M. B. Castro14A. Enrico15A. Gimenez Conca16C. Belli171 Hematologia, Hospital el Cruce, Florencio Varela2 Hematología, Hospital Durand, CABA3 Hematología, Hospital Austral, Pilar4 Hematología, Hospital Aleman5 Hematología, Hospital de Clinicas, CABA6 Hematologia, Sanatorio Britanico, Rosario7 Hematologia, Fundaleu, CABA8 Hematologia, Hospital San Martin, Parana, Entre Rios9 Hematologia, Sanatorio Sagrado Corazon, CABA10 Hematologia, Hospital San Martin, La Plata, Buenos Aires11 Hematologia, Hospital Ramos Mejia, Buenos Aires12 Hematologia, Instituto Alexander Fleming, CABA13 Hematologia, Instituto Privado de Hematología y Hemoterapia, Parana, Entre Rios14 Hematologia, Instituto Conciencia, Neuquen15 Hematologia, Hospital Privado, Cordoba16 Hematologia, Hospital Italiano, La Plata, Buenos Aires17 Hematologia, Hospital Italiano Buenos Aires, CABA18 Hematologia, Academia Nacional de Medicina, Buenos Aires, Argentinahttp://journals.lww.com/10.1097/01.HS9.0000850168.39267.76 |
| spellingShingle | A. Navickas J. González M. M. Rivas M. Clavijo N. Carnelutto M. E. Funes M. J. Mela Osorio R. Mariano M. L. Rapan M. Moirano I. Rey S. Cranco J. E. Giunta R. Ramirez M. B. Castro A. Enrico A. Gimenez Conca C. Belli PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_full | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_fullStr | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_full_unstemmed | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_short | PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS |
| title_sort | pb1829 argentinean real world experience on midostaurin plus intensive chemotherapy vs intensive chemotherapy to treat flt3 positive acute myeloid leukemia patients |
| url | http://journals.lww.com/10.1097/01.HS9.0000850168.39267.76 |
| work_keys_str_mv | AT anavickas pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT jgonzalez pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mmrivas pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mclavijo pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT ncarnelutto pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mefunes pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mjmelaosorio pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT rmariano pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mlrapan pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mmoirano pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT irey pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT scranco pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT jegiunta pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT rramirez pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT mbcastro pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT aenrico pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT agimenezconca pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients AT cbelli pb1829argentineanrealworldexperienceonmidostaurinplusintensivechemotherapyvsintensivechemotherapytotreatflt3positiveacutemyeloidleukemiapatients |